Dendritic cell immunotherapy for HIV infection: from theory to reality.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Immunotherapy

• Publication date

  2009-11-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/imt.09.68PMID 20635918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells.

  2009cited by this paper
• Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes

  2009cited by this paper
• Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures.

  2009cited by this paper
• Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.

  2009cited by this paper
• Cancer immunotherapy by fusions of dendritic cells and tumor cells.

  2009cited by this paper
• A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.

  2009cited by this paper
• Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute TH1 immune responses

  2009cited by this paper
• Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10.

  2009cited by this paper
• Dendritic-cell vaccination for prostate cancer.

  2009cited by this paper
• Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients.

  2009cited by this paper
• Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells.

  2009cited by this paper
• Immunology of TLR-independent vaccine adjuvants.

  2009cited by this paper
• Characterization of Monocyte-derived IFNα-generated Dendritic Cells

  2008cited by this paper
• Dendritic cells in vivo: a key target for a new vaccine science.

  2008cited by this paper
• Regulation of Dendritic Cell Migration by CD74, the MHC Class II-Associated Invariant Chain

  2008cited by this paper
• Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.

  2008cited by this paper
• Mechanisms of dendritic cell-based vaccination against infection.

  2008cited by this paper
• Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses by gag mRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals

  2008cited by this paper
• The challenge of HIV-1 subtype diversity.

  2008cited by this paper
• Mechanisms and consequences of dendritic cell migration.

  2008cited by this paper
• Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis

  2008cited by this paper
• Tuning microenvironments: induction of regulatory T cells by dendritic cells.

  2008cited by this paper
• FOXP3: Not just for regulatory T cells anymore

  2007cited by this paper
• Increased Sequence Diversity Coverage Improves Detection of HIV-Specific T Cell Responses1

  2007cited by this paper
• Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals

  2007cited by this paper
• Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells

  2007cited by this paper
• Steady-state and inflammatory dendritic-cell development

  2007cited by this paper
• High transfection efficiency, gene expression, and viability of monocyte‐derived human dendritic cells after nonviral gene transfer

  2007cited by this paper
• Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants

  2007cited by this paper
• DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

  2007cited by this paper
• Therapeutic Immunization with Human Immunodeficiency Virus Type 1 (HIV-1) Peptide-Loaded Dendritic Cells Is Safe and Induces Immunogenicity in HIV-1-Infected Individuals

  2007cited by this paper
• Antigen crosspresentation by human plasmacytoid dendritic cells.

  2007cited by this paper
• Dendritic cells in a mature age

  2006cited by this paper
• HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

  2006cited by this paper
• Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.

  2006cited by this paper
• Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients.

  2006cited by this paper
• Peptide‐loaded dendritic‐cell vaccination followed by treatment interruption for chronic HIV‐1 infection: A phase 1 trial

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection

  2006cited by this paper
• Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.

  2006cited by this paper
• HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

  2006cited by this paper
• Genetics as a tool to improve cancer outcomes: ethics and policy

  2006cited by this paper
• CpG ODN enhance antigen‐specific NKT cell activation via plasmacytoid dendritic cells

  2005cited by this paper
• Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation1

  2005cited by this paper
• Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection

  2005cited by this paper
• Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction1

  2005cited by this paper
• In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

  2005cited by this paper
• In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients

  2005cited by this paper
• Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.

  2005cited by this paper
• Toll-like receptor control of the adaptive immune responses

  2004cited by this paper
• Dendritic cell immunotherapy: mapping the way

  2004cited by this paper
• Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.

  2004cited by this paper
• Death-defying immunity: do apoptotic cells influence antigen processing and presentation?

  2004cited by this paper
• Mechanisms and functional significance of tumour-induced dendritic-cell defects

  2004cited by this paper
• Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells

  2004cited by this paper
• Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

  2004cited by this paper
• Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

  2004cited by this paper
• Vaccination in Humans Generates Broad T Cell Cytokine Responses1

  2004cited by this paper
• Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.

  2003cited by this paper
• Therapeutic dendritic-cell vaccine for simian AIDS

  2003cited by this paper
• Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

  2003cited by this paper
• Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-α are potent inducers of HIV-specific CD8 T cells

  2003cited by this paper
• Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs

  2003cited by this paper
• Dendritic cells enhance detection of antigen‐specific cellular immune responses by lymphocytes from rhesus macaques immunized with an HIV envelope peptide cocktail vaccine

  2003cited by this paper
• Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.

  2003cited by this paper
• Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences

  2003cited by this paper
• Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces

  2002cited by this paper
• Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1

  2002cited by this paper
• Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells

  2002cited by this paper
• DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.

  2002cited by this paper
• Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

  2001cited by this paper
• Toll-like receptors and innate immunity

  2001cited by this paper
• Dendritic cells: On the move from bench to bedside

  2001cited by this paper
• Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+ T-Cell Responses from Chronically Infected Individuals

  2001cited by this paper
• In Vitro Human Immunodeficiency Virus Eradication by Autologous CD8+ T Cells Expanded with Inactivated-Virus-Pulsed Dendritic Cells

  2001cited by this paper
• Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells

  2001cited by this paper
• Active immunization against cancer with dendritic cells: The near future

  2001cited by this paper
• Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients

  2001cited by this paper
• Toll-like receptors control activation of adaptive immune responses

  2001cited by this paper
• HIV-1 sequence variation: drift, shift, and attenuation.

  2001cited by this paper
• The use of dendritic cells in cancer therapy.

  2001cited by this paper
• Timing the ancestor of the HIV-1 pandemic strains.

  2000cited by this paper
• Maturation and Trafficking of Monocyte-Derived Dendritic Cells in Monkeys: Implications for Dendritic Cell-Based Vaccines1

  2000cited by this paper
• HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response1

  2000cited by this paper
• Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease

  2000cited by this paper
• Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.

  2000cited by this paper
• HIV protease inhibitor-related lipodystrophy syndrome.

  2000cited by this paper
• T Cell Activity After Dendritic Cell Vaccination Is Dependent on Both the Type of Antigen and the Mode of Delivery1

  2000cited by this paper
• In Vivo Persistence of Donor Cells following Adoptive Transfer of Allogeneic Dendritic Cells in HIV-Infected Patients

  2000cited by this paper
• Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy.

  1999cited by this paper
• The nature of the principal type 1 interferon-producing cells in human blood.

  1999cited by this paper
• Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses.

  1999cited by this paper
• Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.

  1999cited by this paper
• Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy.

  1999cited by this paper
• T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

  1999cited by this paper
• HIV vaccine development and evaluation: realistic expectations.

  1998cited by this paper
• A Pilot Clinical Trial of HIV Antigen-Pulsed Allogeneic and Autologous Dendritic Cell Therapy in HIV-Infected Patients

  1998cited by this paper
• Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper

• Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie.

  2015cites this paper
• This information is current as Activation Does Not Correlate with Better T Cell Dendritic Cells : Enhanced Viral Capture HIV-1 Capture and Antigen Presentation by Moris and

  2012cites this paper
• An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV

  2012cites this paper
• Geração in vitro de células T efetoras e células T reguladoras mediada por células dendríticas pulsadas com vírus autólogo de pacientes infectados pelo HIV-1

  2012cites this paper
• Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.

  2011cites this paper